Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics mdpi.com/1799538 #mdpicells via MDPI

Learn your lung segmental #anatomy! 🫁 From Patología Crítica

This is Mjriam Capula with the research team she is working with 🙂 She is the winner of the Short-term Scientific Stay Award 2022 promoted by PCE. Vrije Universiteit Amsterdam is the university she has chosen to carry out her project. 💜 Enjoy your time abroad, Mjriam!

Primo incontro nazionale APIC. Pazienti, famiglie e medici insieme nella lotta al colangiocarcinoma! #APIC Lorenza Rimassa AMMF Global Cholangiocarcinoma Alliance ENS-CCA Cholangiocarcinoma Foundation EASLnews

Today is World Pancreatic Cancer Day 🌍🌎🌏 Let's raise awareness!💜

🔥Association of Antibiotic With Survival Among Patients With #PDAC Receiving Chemotherapy JAMA Network Open doi.org/10.1001/jamane… 🔎🇺🇸3850 pts -> 2178 with antibiotics 👉⬆️ OS among pts treated with gemcitabine, but not 5-Fu 🤔And now? Enough RWE for prospective trial? ESMO - Eur. Oncology

🔥Comparison of genomic profiling of ctDNA in pancreaticobiliary malignancies in plasma & bile ACS Journal Cancer doi.org/10.1002/cncr.3… 🔎🇯🇵RWD 83 pts 👉 bile: GA in 55% 👉🩸: GA in 24% 👉Overall: 23/83 with 💊🎯 🧐no tissue? Get bile and/or🩸 ! ESMO - Eur. Oncology EASL Education #livertwitter

🔥Hot of the press: Adjuvant therapy of biliary tract cancers Therapeutic Advances in Medical Oncology doi.org/10.1177/175883… 🔎We summarize the latest evidence (BCAT, Prodigy-12, BILCAP, ASCOT, STAMP..) and highlight future prospects 👉ACTICCA awaited... ESMO - Eur. Oncology EASL Education ENS-CCA #livertwitter

🔥Hot off the Press Pancreatic Ductal #Adenocarcinoma and Immune Checkpoint Inhibitors: The Gray Curtain of #Immunotherapy and Spikes of Lights by Rita Balsano, Valentina Zanuso et al 👉mdpi.com/1718-7729/30/4…

NORPACT-1 trial #ASCO23 ❓Neoadyuvant mFOLFIRINOX for RESECTABLE #PDAC 🏴‍☠️4 cycles before surgery (8 after) 🔪82% (89% if surgery upfront) underwent resection ❌No improvement on OS / R0 resection in ITT population 👉CONCLUSION: Upfront surgery for RESECTABLE PDAC OncoAlert

🔥Recent advances in systemic therapy for advanced intrahepatic cholangiocarcinoma 👏Comprehensive & detailed update on 💊options for CCC > IO & 🎯therapies by Changhoon Yoo, MD & colleagues 👇doi.org/10.1159/000531… in Liver Cancer ESMO - Eur. Oncology EASL Education OncoAlert ILCA

#LiverTwitter, exciting news! 🎉 My abstract has been accepted for #EASLCongress 2024 in Milan, Italy, from June 5-8. I hope to see you there – secure your spot now and let's revolutionise liver science together! 💡👩‍🔬 ctt.ec/L9nQl+ @EASLNews

🎯Outstanding works from my colleagues & rising stars Rita Balsano & Giulia Tesini👏. Posters highlight different outcomes of #iCCApts w vs w/o underlying #liverdisease & the #immunelandscape of those responding to #immunotherapy. #HBPteam Humanitas University #EASLCongress2024 EASLnews

Angelo Pirozzi Rita Balsano Humanitas University EASLnews We would like to inform you that your post has been successfully published on @Oncodaily. Thank you for sharing! oncodaily.com/blog/80650.html

Next, Dr. Rita Balsano from the Humanitas Research Hospital discusses the immune and molecular profiling of BTC patients undergoing chemo-immunotherapy. #PrecisionBTCNet #ENSCCA #Krakow2024 🔬🇵🇱

Prof. Lorenza Rimassa discusses rationale of neadjuvant therapy in BTC: where are we now? 🔎#PrecisionBTCNet #ENSCCA

👉Rita Balsano discussing #immunesignatures and #molecularprofiling of #BTCs pts treated w CT+immunotherapy🔥 Humanitas University #ENSCCA #Kracow2024

Thank you once again to all our attendees for making the ENSCCA/Precision-BTC-Network Joint Meeting an unforgettable event! Your energy and contributions made it truly special. Thank you Krakow for hosting us! 🇵🇱 Looking forward to our next gathering! #ENSCCA #PrecisionBTCNet